Century Therapeutics, Inc. (IPSC) vs X4 Pharmaceuticals, Inc. (XFOR)
A side-by-side comparison of Century Therapeutics, Inc. and X4 Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
IPSC
Century Therapeutics, Inc.
$1.32HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
XFOR
X4 Pharmaceuticals, Inc.
$2.77HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — IPSC vs XFOR
growth of $100 · dividends reinvested · last 5yIPSC -93.5% (-42.1%/yr)XFOR -98.8% (-58.8%/yr)IPSC compounded faster over this window
Log scale — wide-divergence pair
IPSC XFOR
IPSC vs XFOR: by the numbers
- •XFOR is the larger company ($261M vs $239M market cap).
- •Both run net losses; IPSC's is the smaller (-8.78% vs -568.80% net margin).
Metrics side by side
Valuation
| Metric | IPSC | XFOR |
|---|---|---|
| P/S ratio | N/A | 16.49 |
| P/B ratio | 1.03 | 1.68 |
Profitability
| Metric | IPSC | XFOR |
|---|---|---|
| Gross margin | 88.00% | 81.22% |
| Operating margin | -13.78% | -247.44% |
| Net margin | -8.78% | -568.80% |
| ROE | -47.25% | -57.98% |
| ROIC | -43.69% | -37.61% |
Growth (annualized)
| Metric | IPSC | XFOR |
|---|---|---|
| Total return CAGR (5Y) | -42.05% | -55.06% |
Frequently asked
- How have IPSC and XFOR total returns compared?
- Over the past 5 years, IPSC delivered -42.05% and XFOR delivered -55.06% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.